In the above-named article by Mills EG, Yang L, Nielsen MF, Kassem M, Dhillo WS, and Comninos AN (Endocrine Reviews 2021; doi: 10.1210/endrev/bnab015), the following errors occurred during the production process in the published paper:
In the sentence on page 18 “A more recent meta-analysis of more than 1000 menopausal women reported that estrogen plus progesterone therapy resulted in a superior increase in lumbar BMD compared to estrogen therapy alone (212), highlighting an additive action for progesterone”, the words “of randomized controlled trials” were omitted in the original publication. The sentence now reads “A more recent meta-analysis of randomized controlled trials of more than 1000 menopausal women reported that estrogen plus progesterone therapy resulted in a superior increase in lumbar BMD compared to estrogen therapy alone (212), highlighting an additive action for progesterone.”
In the sentence on page 18 “However, these findings likely represent the effects of supraphysiological progesterone levels that decrease levels of associated beneficial hormones (particularly estrogen),” the word “progesterone” in the original publication should have been “progestin.” The sentence now reads “However, these findings likely represent the effects of supraphysiological progestin levels that decrease levels of associated beneficial hormones (particularly estrogen).”
The sentence on page 18 “SOD therefore provides a useful context for the study of progesterone effects on female bone” included no reference citation in the original publication. A citation of the following reference has now been added: Danni L, Hitchcock CL, Barr SI, Yu T, Prior JC. Negative spinal bone mineral density changes and subclinical ovulatory disturbances - prospective data in healthy premenopausal women with regular menstrual cycles. Epidemiol Rev. 2014;36:137-47.
The publisher acknowledges the errors.
The publication has been corrected online.